171 related articles for article (PubMed ID: 33063933)
1. Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
Manisterski M; Benish M; Levin D; Shiran SI; Sher O; Gortzak Y; Elhasid R
Pediatr Blood Cancer; 2021 Feb; 68(2):e28769. PubMed ID: 33063933
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
Wu SY; McCavit TL; Cederberg K; Galindo RL; Leavey PJ
J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
[TBL] [Abstract][Full Text] [Related]
3. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
Gehle S; Quinsey C; McShane D; Thompson P; Quezada G
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e921-e923. PubMed ID: 37526359
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted therapy for infantile myofibromatosis in children.
Levine E; Fréneaux P; Schleiermacher G; Brisse H; Pannier S; Teissier N; Mesples B; Orbach D
Pediatr Blood Cancer; 2012 Jul; 59(1):115-20. PubMed ID: 22038698
[TBL] [Abstract][Full Text] [Related]
5. Infantile myofibromatosis.
Larralde M; Ferrari B; Martinez JP; Barbieri MAF; Méndez JH; Casas J
An Bras Dermatol; 2017; 92(6):854-857. PubMed ID: 29364448
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Gandhi MM; Nathan PC; Weitzman S; Levitt GA
J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
[TBL] [Abstract][Full Text] [Related]
7. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
[TBL] [Abstract][Full Text] [Related]
8. A rare case of infantile myofibromatosis and review of literature.
Hausbrandt PA; Leithner A; Beham A; Bodo K; Raith J; Windhager R
J Pediatr Orthop B; 2010 Jan; 19(1):122-6. PubMed ID: 19738495
[TBL] [Abstract][Full Text] [Related]
9. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.
Azzam R; Abboud M; Muwakkit S; Khoury N; Saab R
Pediatr Blood Cancer; 2009 Feb; 52(2):308. PubMed ID: 18937326
[No Abstract] [Full Text] [Related]
10. Solitary infantile myofibromatosis: report of two cases.
Kuo FY; Huang SC; Eng HL; Chuang JH; Chen WJ
Chang Gung Med J; 2002 Jun; 25(6):393-8. PubMed ID: 12173669
[TBL] [Abstract][Full Text] [Related]
11. Infantile myofibromatosis: a series of 28 cases.
Mashiah J; Hadj-Rabia S; Dompmartin A; Harroche A; Laloum-Grynberg E; Wolter M; Amoric JC; Hamel-Teillac D; Guero S; Fraitag S; Bodemer C
J Am Acad Dermatol; 2014 Aug; 71(2):264-70. PubMed ID: 24894456
[TBL] [Abstract][Full Text] [Related]
12. [Infantile myofibromatosis. Study of a case using whole body ultrasound and MRI].
Machan K; Bravo Bravo C; Martínez-León MI; Affumicato L
Radiologia; 2014; 56(1):80-3. PubMed ID: 22118778
[TBL] [Abstract][Full Text] [Related]
13. New Therapeutic Approach in an Infant With Systemic Myofibromatosis and Intestinal Hemorrhage.
Salvador C; Entenmann A; Crazzolara R; Kropshofer G
J Pediatr Hematol Oncol; 2022 Apr; 44(3):109-112. PubMed ID: 34486566
[TBL] [Abstract][Full Text] [Related]
14. Imaging findings in seven cases of congenital infantile myofibromatosis with cerebral, spinal, or head and neck involvement.
Holzer-Fruehwald L; Blaser S; Rossi A; Fruehwald-Pallamar J; Thurnher MM
Neuroradiology; 2012 Dec; 54(12):1389-98. PubMed ID: 23223874
[TBL] [Abstract][Full Text] [Related]
15. Multicentric infantile myofibromatosis with extensive involvement limited to bone.
Luque-Cabal M; Obregón-Martínez E; Díez-Blanco M; Álvarez-García M; Fernández-Pérez G
Skeletal Radiol; 2022 Jul; 51(7):1503-1510. PubMed ID: 34865192
[TBL] [Abstract][Full Text] [Related]
16. Solitary cutaneous infantile myofibroma as a hallmark of myofibromatosis: Two cases and review of the literature.
Braun M; Pascual M; Mully T; Phelps A; Prok L; Shah SD; Kohn LL
Pediatr Dermatol; 2022 May; 39(3):438-442. PubMed ID: 35297087
[TBL] [Abstract][Full Text] [Related]
17. Infantile myofibromatosis: case report of a solitary hand lesion with emphasis on differential diagnosis and management.
Netscher DT; Eladoumikdachi F; Popek EJ
Ann Plast Surg; 2001 Jan; 46(1):62-7. PubMed ID: 11192039
[TBL] [Abstract][Full Text] [Related]
18. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
[TBL] [Abstract][Full Text] [Related]
19. Use of 2-chlorodeoxyadenosine to treat infantile myofibromatosis.
Williams W; Craver RD; Correa H; Velez M; Gardner RV
J Pediatr Hematol Oncol; 2002 Jan; 24(1):59-63. PubMed ID: 11902743
[TBL] [Abstract][Full Text] [Related]
20. Infantile myofibromatosis: a solitary lesion involving the upper lip.
Lo LJ; Hsueh C; Noordhoff MS; Chen YR
Ann Plast Surg; 1997 Dec; 39(6):624-7. PubMed ID: 9418923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
